Table: Cytori Cell Research Institute -2022/23 group results

ADR Biomedical Holdings

12/05/2023 08:30

May 12 (Reuters)- 
          Cytori Cell Research Institute, Inc. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended       Year to        NEXT   
               Mar 31, 2023    Mar 31, 2022    Mar 31, 2024     YEAR     
                  LATEST         YEAR-AGO        COMPANY       COMPANY   
                 RESULTS          RESULTS        FORECAST    H1 FORECAST 
  Sales            2.14            1.34            1.79                  
               (+60.6 pct)      (-3.8 pct)     (-16.5 pct)               
  Operating    loss 794 mln    loss 462 mln    loss 21 mln               
  Recurring    loss 862 mln    loss 418 mln    loss 80 mln               
  Net
  Net           loss 1.06       loss 77 mln    loss 30 mln               
  EPS        loss 118.71 yen   loss 8.79 yen  loss 3.44 yen              
  Ann Div          NIL              NIL                                  
  -Q2 Div          NIL              NIL                                  
  -Q4 Div          NIL              NIL                                  
  
  NOTE - Cytori Cell Research Institute, Inc..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3750.T